Data Methods

Learn more about the data that informs AHEAD.

Two people looking at each other, smiling

Linkage to HIV medical care indicator icon Linkage to HIV medical care

The linkage to HIV medical care indicator is measured by documentation of at least 1 CD4 or viral load test performed ≤1 month after diagnosis among persons aged ≥13 years. This indicator is only available for states with complete laboratory data (at least 95% of laboratory results are reported to the surveillance programs and transmitted to CDC). For the baseline year 2017, linkage to HIV medical care was available for 41 states and Washington, District of Columbia: Alabama, Alaska, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming. There are 41 areas with complete lab reporting for 2018 however, the composition of the states changed. In 2018, linkage was available for Nevada but not available for Connecticut.

Nevertheless, completeness of report¬ing varied among states and local jurisdictions.

  • EHE areas without laws requiring complete reporting:
    • Idaho
    • New Jersey
    • Pennsylvania
  • EHE areas with incomplete reporting:
    • Arizona
    • Arkansas
    • Connecticut (for 2018 only)
    • Kansas
    • Kentucky
    • Nevada (for 2017 only)
    • Vermont
    • Puerto Rico

Linkage to care data by quarter will be calculated for the cumulative number of persons who received an HIV diagnosis by the quarter of interest for the specified calendar year. A 3-month reporting lag is required for calculating linkage to care due to known delays in reporting of laboratory data (e.g., linkage to care through September 2019 is calculated using data reported to CDC’s National HIV Surveillance System through December 2019). Data presented by quarter are preliminary.

More information can be found at: HIV Surveillance Report Supplemental Report Volume 25, Number 1.